Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suga Balanz is a proprietary nutraceutical formulation developed by Phyto Biotech, an Indian biotechnology company specializing in standardized herbal extracts. The product is designed to assist in the management of blood glucose levels in individuals with type 2 diabetes or prediabetes. While the specific formulation details are proprietary, it typically utilizes a blend of phyto-molecules derived from traditional medicinal plants such as *Gymnema sylvestre*, *Pterocarpus marsupium*, and *Momordica charantia*. These components are believed to work synergistically to improve insulin sensitivity, stimulate pancreatic beta-cell function, and inhibit the absorption of glucose in the gastrointestinal tract. It is marketed as a natural dietary supplement to support metabolic health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Suga Balanz.